CSPC Pharmaceutical Group Limited CSPCY
Set alert
3.94 USD -0.17 -4.21%
At close · Oct 30
3.94 Day range 3.94
3.26 52-week range 5.46
- YTD
- -8.58%
- 1 year
- +4.23%
- Open
- 3.94
- Prev close
- 4.11
- Mkt cap
- 11.23B
- Vol
- 598
- Avg vol
- 1.46K
- EPS
- 0.37
- P/E
- 10.65
More statistics
- Low
- 3.94
- High
- 3.94
News
4 months ago reuters.com
AstraZeneca signs CSPC China deal for experimental kidney disease drugs
AstraZeneca has entered into a deal worth up to $1.77 billion with CSPC Pharmaceutical Group to discover and develop experimental medicines with the potential to treat kidney diseases, the Chinese…
9 months ago proactiveinvestors.co.uk
AstraZeneca obesity tie-up with CSPC seen as shrewd move
AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) licensing deal on Friday signals a plausible effort by the FTSE 100 group to grab a piece of a booming market for obesity treatments, analysts said, with still…
10 months ago defenseworld.net
CSPC Pharmaceutical Group (OTCMKTS:CSPCY) Shares Down 0.5% – Here’s What Happened
CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY - Get Free Report)'s share price traded down 0.5% during trading on Thursday. The company traded as low as C$3.88 and last traded at C$3.91. 35,649…